Trials / Conditions / Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

6 registered clinical trials studyying Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squ NCT07156227	National Cancer Institute (NCI)	Phase 1
Recruiting	High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Conc NCT06992427	Alliance for Clinical Trials in Oncology	Phase 3
Recruiting	Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone NCT06568172	National Cancer Institute (NCI)	Phase 3
Recruiting	Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f NCT06532279	NRG Oncology	Phase 2
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Suspended	Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advan NCT05050162	NRG Oncology	Phase 2 / Phase 3